bevazicumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for bevazicumab, covering 2019-08-21 to 2019-08-21. Get the full timeline:
Most recent: Clinical Trial Update: Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy [Phase 1, Phase 2]